INDP 8-K 2026-09-30
Indaptus Therapeutics, Inc. (INDP) 8-K dated 2026-09-30 — accession 0001493152-26-045040.
Indaptus Therapeutics, Inc. (INDP) is a biotechnology company listed on US.
Indaptus Therapeutics, Inc. filed a 8-K on 2026-09-30. Accession 0001493152-26-045040.
This 8-K covers: Material agreement (Item 1.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for INDP is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The INDP SEC hub lists recent forms. The stock page is the research view.